FDA
approval
· 2013-07-10
FDA Approved: MONISTAT 3 3 DAY — Supplemental Application (Insight Pharmaceuticals LLC)
Summary
The FDA lists a supplemental application for MONISTAT 3 3 DAY (miconazole nitrate) submitted by Insight Pharmaceuticals LLC under NDA 020827. The entry indicate…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MONISTAT 3 3 DAY (MICONAZOLE NITRATE)